Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tesseract Health

Explore full profile

Building a portable, affordable device for monitoring and preventing disease through the eye

Guilford, United StatesFounded 2018Health Tech & Medtech
Valuation $100–500M Latest valuation · 2021
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Tesseract Health and the history behind them.

About Tesseract Health

Identifeye Health leverages artificial intelligence to revolutionize the field of medical diagnostics by focusing on retinal imaging. The company has developed an innovative platform that allows non-specialists to capture and analyze retinal images in real-time, providing immediate health insights. This technology democratizes access to critical health information, enabling earlier diagnosis and treatment of diseases. Identifeye Health primarily serves healthcare providers, including clinics and hospitals, operating within the medical diagnostics market. The business model is based on selling its imaging platform and associated services to these healthcare providers. Revenue is generated through the sale of the platform, subscription fees for ongoing access to the AI algorithms, and potential partnerships with healthcare institutions.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Guilford, United States
Employees
34
Open positions
None listed
Dealroom signal
63.9/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Ophthalmology, Medical Imaging, Health Diagnostics, AI for medical imaging, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Tesseract Health.

See all news

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2021 $80M $320M Glenview Capital · Foresite Capital · Opaleye Management
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Tesseract Health website traffic

Latest recorded traffic for Tesseract Health is 2.3K monthly website visits, up 0% over the last three months. Tesseract Health's team declined 37% over the past year.

Latest monthly visits2.3K 3-month web change0% 1-year team growth-37%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tesseract Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tesseract Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.